Underuse of Radiotherapy in Lung Cancer Has Negative Consequences for Patients

Tovar, I.; Expósito, José; Jaen, J.; Alonso, E.

doi:10.1097/jto.0b013e3182745640

Cited by 13 publications

(8 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The European ESTRO QUARTS project [32] recommended RT in up to 61% of LC patients. In the present survey, the irradiation rate was 20%, 4% higher than recorded in our region in 2004 (17% relative increase) but still low according to the estimated radiation rate, resulting in an underuse of RT for lung cancer [33]. …”

Section: Discussionmentioning

confidence: 88%

Pattern of use of radiotherapy for lung cancer: a descriptive study

Tovar

Expósito

Jaen³

et al. 2014

BMC Cancer

Self Cite

View full text Add to dashboard Cite

BackgroundLung cancer remains one of the most prevalent forms of cancer. Radiotherapy, with or without other therapeutic modalities, is an effective treatment. Our objective was to report on the use of radiotherapy for lung cancer, its variability in our region, and to compare our results with the previous study done in 2004 (VARA-I) in our region and with other published data.MethodsWe reviewed the clinical records and radiotherapy treatment sheets of all patients undergoing radiotherapy for lung cancer during 2007 in the 12 public hospitals in Andalusia, an autonomous region of Spain. Data were gathered on hospital, patient type and histological type, radiotherapy treatment characteristics, and tumor stage.Results610 patients underwent initial radiotherapy. 37% of cases had stage III squamous cell lung cancer and were treated with radical therapy. 81% of patients with non-small and small cell lung cancer were treated with concomitant chemo-radiotherapy and the administered total dose was ≥ 60 Gy and ≥ 45 Gy respectively. The most common regimen for patients treated with palliative intent (44.6%) was 30 Gy. The total irradiation rate was 19.6% with significant differences among provinces (range, 8.5-25.6%; p < 0.001). These differences were significantly correlated with the geographical distribution of radiation oncologists (r = 0.78; p = 0.02). Our results were similar to other published data and previous study VARA-I.ConclusionsOur results shows no differences according to the other published data and data gathered in the study VARA-I. There is still wide variability in the application of radiotherapy for lung cancer in our setting that significantly correlates with the geographical distribution of radiation oncologists.

show abstract

Section: Discussionmentioning

confidence: 88%

Pattern of use of radiotherapy for lung cancer: a descriptive study

Tovar

Expósito

Jaen³

et al. 2014

BMC Cancer

Self Cite

View full text Add to dashboard Cite

show abstract

“…El tratamiento quimioterápico se ha afianzado y predomina con porcentajes algo mayores del 50%, de acuerdo a lo encontrado en otros estudios españoles 22,26 , mientras que la cirugía con sus lógicas variaciones en los diferentes años llega a una media en el entorno del 15%, similar o algo inferior a la referida en otros trabajos españoles 22,23,29 . Los cambios en las indicaciones, combinaciones y mejoras técnicas, que con los años se han ido introduciendo en el tratamiento radioterápico, dificultan la comparación de nuestras cifras (tabla 5) con las de otros estudios cuyos porcentajes de empleo varían entre el 4,7 y el 34,5% 22,26,30 . Por último, se confirma la tendencia decreciente del uso de tratamiento solo sintomático que en 2012 se ha aplicado al 23,46% de los enfermos, en el entorno de los indicados en otros lugares españoles (19 al 30%) 22,23,26,29 .…”

Section: Discussionunclassified

Cáncer de pulmón en la provincia de Ávila. Tasas de incidencia, epidemiología del año 2012 y tendencias en los últimos 20 años

Hernández-Hernández

Vega-Herrero

Iglesias-Heras

et al. 2015

SEMERGEN - Medicina de Familia

View full text Add to dashboard Cite

“…13 Nevertheless, it is important to remind that the underuse of radiotherapy should be a matter of concern, given its negative and measurable impact on the survival of patients. 14 The White Book of Radiation Oncology, published by the Spanish Society of Radiation Oncology (SEOR), 13 provides a comprehensive overview of the current state of the specialty in Spain and the outlook for the future. The book, which includes contributions from more than 50 professionals, was written as a reference for physicians, health-care administrators and hospital managers.…”

Section: Current Challenges and Conclusionmentioning

confidence: 99%